EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma

Kang He, Jingze Li, Xuemiao Huang, Weixin Zhao, Kai Wang, Taiwei Wang, Junyu Chen, Zeyu Wang, Jiang Yi, Shuhua Zhao, Lijing Zhao

Frontiers in Oncology · 27.01.2023 · 13

DOI: 10.3389/fonc.2023.1090779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 27.01.2023. Verfasst von Kang He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, School of Nursing, Jilin University, Changchun, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence and mortality of uterine corpus endometrial carcinoma (UCEC) are increasing yearly. There is currently no screening test for UCEC, and progress in its treatment is limited. It is important to identify new biomarkers for screening, diagnosing and predicting the outcomes of UCEC. A large number of previous studies have proven that KNL1 is crucial in the development of lung cancer, colorectal cancer and cervical cancer, but there is a lack of studies about the role of KNL1 in the development of UCEC.

Methods

The mRNA and protein expression data of KNL1 in The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and UALCAN databases and related clinical data were used to analyze the expression differences and clinical correlations of KNL1 in UCEC. A total of 108 clinical samples were collected, and the results of bioinformatics analysis were verified by immunohistochemistry. KNL1 and its related differentially expressed genes were used to draw a volcano map, construct a PPI protein interaction network, and perform gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), gene set enrichment analysis (GSEA) and immune infiltration analysis to predict the function of KNL1 during UCEC progression. The prognostic data of TCGA and 108 clinical patients were used to analyze the correlation of KNL1 expression with the survival of patients, and KM survival curves were drawn. The UCEC cell lines Ishikawa and Hec-1-A were used to verify the function of KNL1.

Results

KNL1 is significantly overexpressed in UCEC and is associated with a poor prognosis. KNL1 overexpression is closely related to cell mitosis, the cell cycle and other functions and is correlated with the International Federation of Gynecology and Obstetrics (FIGO) stage, histological grade and other characteristics of UCEC patients. Knockdown of KNL1 expression in UCEC cell lines can inhibit their proliferation, invasion, metastasis and other phenotypes.

Conclusion

KNL1 is a prognostic and diagnostic biomarker associated with immune evasion in patients with UCEC.

Schlagwörter

Stichwörter der Autor:innen

KNL1bioinformaticsbiomarkerprognosisuterine corpus endometrial carcinoma

Autor:innen und Institutionen

  • Department of Rehabilitation, School of Nursing, Jilin University, Changchun, China.
  • The Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, China.
  • Department of Rehabilitation, The Second Hospital of Jilin University, Changchun, Jilin, China.

Zitieren

APA

He, K., Li, J., Huang, X., Zhao, W., Wang, K., Wang, T., Chen, J., Wang, Z., Yi, J., Zhao, S., & Zhao, L. (2023). KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1090779

Vancouver

He K, Li J, Huang X, Zhao W, Wang K, Wang T, et al. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1090779

BibTeX
@article{He2023,
  author = {He, Kang and Li, Jingze and Huang, Xuemiao and Zhao, Weixin and Wang, Kai and Wang, Taiwei and Chen, Junyu and Wang, Zeyu and Yi, Jiang and Zhao, Shuhua and Zhao, Lijing},
  title = {KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1090779}
}
Kostenlos starten →